Cargando…

Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax

Background. Efficacy of standard dose of primaquine (PQ) as antirelapse for P. vivax has decreased. We aimed to assess efficacy of different PQ regimens. Methods. It was an open label, randomized, controlled, parallel group, assessor blind study comparing antirelapse efficacy of 3 PQ regimens (B = 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajgor, D. D., Gogtay, N. J., Kadam, V. S., Kocharekar, M. M., Parulekar, M. S., Dalvi, S. S., Vaidya, A. B., Kshirsagar, N. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176909/ https://www.ncbi.nlm.nih.gov/pubmed/25295216 http://dx.doi.org/10.1155/2014/347018

Ejemplares similares

Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping
por: Beck, Hans-Peter, et al.
Publicado: (2016)

Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon
por: Graf, Paul C. F., et al.
Publicado: (2012)

Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency
por: Taylor, Walter R J, et al.
Publicado: (2019)

Corrigendum to: Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency
por: Taylor, Walter R J, et al.
Publicado: (2020)

Evaluation of pharmacokinetics of single-dose primaquine in undernourished versus normally nourished children diagnosed with Plasmodium vivax malaria in Mumbai
por: Gogtay, NJ, et al.
Publicado: (2021)

The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial
por: Cheah, Phaik Yeong, et al.
Publicado: (2018)

Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study
por: Pareek, Anil, et al.
Publicado: (2015)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
por: Reddy, Pavani, et al.
Publicado: (2006)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012)

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022)

A Comparison of Two Short-Course Primaquine Regimens for the Treatment and Radical Cure of Plasmodium vivax Malaria in Thailand
por: Pukrittayakamee, Sasithon, et al.
Publicado: (2010)

The effect of SNPs in CYP450 in chloroquine/primaquine Plasmodium vivax malaria treatment
por: Sortica, Vinicius A, et al.
Publicado: (2016)

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
por: Milligan, Rachael, et al.
Publicado: (2019)

Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India
por: Anvikar, Anupkumar R., et al.
Publicado: (2022)

A Randomised Trial of an Eight-Week, Once Weekly Primaquine Regimen to Prevent Relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan
por: Leslie, Toby, et al.
Publicado: (2008)

Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area
por: Wångdahl, Andreas, et al.
Publicado: (2021)

Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysis
por: Zuluaga-Idarraga, Lina Marcela, et al.
Publicado: (2015)

Therapeutic efficacy of chloroquine and primaquine for Plasmodium vivax malaria treatment in southeast Iran
por: Heidari, Aliehsan, et al.
Publicado: (2012)

Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal
por: Rijal, Komal Raj, et al.
Publicado: (2019)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
por: Thriemer, Kamala, et al.
Publicado: (2020)

Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure
por: Olvany, Jasmine M., et al.
Publicado: (2022)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India
por: Saravu, Kavitha, et al.
Publicado: (2016)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2017)

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
por: Townell, Nicola, et al.
Publicado: (2012)

Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum
por: Wampfler, Rahel, et al.
Publicado: (2017)

Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters
por: Popovici, Jean, et al.
Publicado: (2021)

Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan
por: Hamid, Muzamil Mahdi Abdel, et al.
Publicado: (2018)

A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]
por: Gogtay, NJ, et al.
Publicado: (2006)

Therapeutic assessment of chloroquine–primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India
por: Rishikesh, Kumar, et al.
Publicado: (2015)

Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens
por: Chu, Cindy S., et al.
Publicado: (2017)

Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil
por: Corder, Rodrigo M., et al.
Publicado: (2020)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
por: Taylor, Walter R. J., et al.
Publicado: (2023)

Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
por: Baird, Kevin
Publicado: (2015)

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
por: Chamnanphon, Monpat, et al.
Publicado: (2020)

Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens
Publicado: (2015)

Erratum to: Therapeutic assessment of chloroquine–primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India
por: Rishikesh, Kumar, et al.
Publicado: (2016)

Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan
por: Wangchuk, Sonam, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b4gj7lak7iil1c03ktrc229vko